- Home
- ALNY vs EOG Comparison
ALNY vs EOG Comparison
Compare ALNY & EOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALNY
- EOG
- Stock Information
- Founded
- ALNY 2002
- EOG 1985
- Country
- ALNY United States
- EOG United States
- Employees
- ALNY N/A
- EOG N/A
- Industry
- ALNY Biotechnology: Pharmaceutical Preparations
- EOG Oil & Gas Production
- Sector
- ALNY Health Care
- EOG Energy
- Exchange
- ALNY Nasdaq
- EOG Nasdaq
- Market Cap
- ALNY 59.2B
- EOG 65.3B
- IPO Year
- ALNY 2004
- EOG N/A
- Fundamental
- Price
- ALNY $459.28
- EOG $119.47
- Analyst Decision
- ALNY Strong Buy
- EOG Buy
- Analyst Count
- ALNY 27
- EOG 23
- Target Price
- ALNY $420.73
- EOG $141.55
- AVG Volume (30 Days)
- ALNY 1.1M
- EOG 2.4M
- Earning Date
- ALNY 10-30-2025
- EOG 11-06-2025
- Dividend Yield
- ALNY N/A
- EOG 3.47%
- EPS Growth
- ALNY N/A
- EOG N/A
- EPS
- ALNY N/A
- EOG 10.30
- Revenue
- ALNY $2,461,963,000.00
- EOG $22,798,000,000.00
- Revenue This Year
- ALNY $58.97
- EOG $2.07
- Revenue Next Year
- ALNY $38.81
- EOG $10.07
- P/E Ratio
- ALNY N/A
- EOG $11.42
- Revenue Growth
- ALNY 5.01
- EOG N/A
- 52 Week Low
- ALNY $205.87
- EOG $102.52
- 52 Week High
- ALNY $469.81
- EOG $138.18
- Technical
- Relative Strength Index (RSI)
- ALNY 70.91
- EOG 47.81
- Support Level
- ALNY $444.66
- EOG $116.06
- Resistance Level
- ALNY $458.30
- EOG $126.12
- Average True Range (ATR)
- ALNY 10.97
- EOG 2.46
- MACD
- ALNY -3.77
- EOG -0.37
- Stochastic Oscillator
- ALNY 71.78
- EOG 32.36
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
About EOG EOG Resources Inc.
EOG Resources is an oil and gas producer with acreage in several US shale plays, primarily in the Permian Basin and the Eagle Ford. At the end of 2024, it reported net proven reserves of 4.7 billion barrels of oil equivalent. Net production averaged roughly 1,062 thousand barrels of oil equivalent per day in 2024 at a ratio of 69% oil and natural gas liquids and 31% natural gas.